Capitol Hill Capsules

And pharma's Special K street team has prevented a ban on reverse payments from getting out of the Senate, according to the Associated Press. Reverse payments are those made by brand-name drug manufacturers to generics maker to keep generics off the market longer. Nearly $40 billion in spending on K street by generic and brand-name drug companies over the last year has left Sen. Herb Kohl's (D-WI) pro-generics bill stranded in the Senate.
(from The Prescription Project Weekly Reader of Community Catalyst)